Bright Minds’ stock explodes after $35M placement, pain drug news
Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped more than 100% in early-morning trading Friday after the psychedelic drug developer announced a $35 million private placement, capping a week of extreme volatility. The Vancouver-based company said it plans to issue common shares at $21.70 each, with an option for prefunded warrants at $21.699, according to […]
